Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharma
STAT+

‘I recognize the responsibility I have’: At #JPM18, a Big Pharma female CEO weighs in on diversity

  • Rebecca Robbins

By Rebecca Robbins Jan. 10, 2018

Reprints
Emma Walmsley
Emma Walmsley, chief executive officer of GlaxoSmithKline, walks with Vittorio Colao, CEO of Vodafone Group, in October. Carl Court/Getty Images

SAN FRANCISCO — At a J.P. Morgan Healthcare Conference that’s been dominated by talk of the hurdles that women face in the industry, GlaxoSmithKline’s (GSK) Emma Walmsley, a rare female CEO of a big pharmaceutical company, got a timely question.

How do you think about cultivating diversity in GSK’s leadership?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
52 weeks, 52 faces: Obituaries narrate lives lost to…
52 weeks, 52 faces: Obituaries narrate lives lost to the opioid epidemic
Under protest, FDA to convene advisory panel to review…
Under protest, FDA to convene advisory panel to review controversial cell therapy for ALS
Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
California judge deals GSK a setback as first Zantac…
California judge deals GSK a setback as first Zantac lawsuit will now go to trial

Recommended Stories